cell-therapy

Documents about cell-therapy

• Precision T Cell Engineering via ZAP70 Modulation, Data-Driven Modeling, and In Vivo Delivery#651658eScholarship
• An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma#807799ClinicalTrials.gov
• IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL#827837ClinicalTrials.gov
• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma#840145ClinicalTrials.gov
• Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)#843245ClinicalTrials.gov
• Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma#850409ClinicalTrials.gov
• Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC#858680ClinicalTrials.gov
• CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus#862379ClinicalTrials.gov
• ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma#172304ClinicalTrials.gov
• Artificial Intelligence and the Transformation of Cell and Gene Therapy Development.#848NCBI PubMed Central
• Mechanical compression reprograms cell states associated with patient survival and therapy response#4803Europe PMC
• Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease#123434ClinicalTrials.gov
• A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer#125859ClinicalTrials.gov
• Single-cell RNA sequencing reveals pancreatic cancer microenvironment heterogeneity for precision therapy.#135801NCBI PubMed Central
• IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma#208438ClinicalTrials.gov
• Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)#230424ClinicalTrials.gov
• Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma#252987ClinicalTrials.gov
• Cardiovascular Effects of CART Cell Therapy#300244ClinicalTrials.gov
• Identifying Cell State Vulnerabilities in Pancreatic Cancer#347595Harvard DASH
• Stem Cell Therapy for Traumatic Brain Injury: Translational Mechanisms, Biomarkers, and Clinical Trials.#362103NCBI PubMed Central
• Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer#373657ClinicalTrials.gov
• Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy#384093CiNii
• Clinical Application of Stem Cell Educator Therapy in Alopecia Areata#387290ClinicalTrials.gov
• Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma#444871ClinicalTrials.gov
• Predictive Models for Toxicities after CAR T-cell Therapy: Challenges and Opportunities.#449836NCBI PubMed Central
• CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy#623510ClinicalTrials.gov
• CAR T Cell Therapy in Lung Cancer: Overcoming Tumor Microenvironment-Mediated Barriers.#653447NCBI PubMed Central
• BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy#825652ClinicalTrials.gov
• Stem Cell Therapy in Autism Spectrum Disorders#841270ClinicalTrials.gov
• Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung Cancer#856466ClinicalTrials.gov
• PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer#253003ClinicalTrials.gov
• Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer#805135ClinicalTrials.gov
• Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib#829067ClinicalTrials.gov
• NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer#854144ClinicalTrials.gov
• Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial#349967ClinicalTrials.gov
• Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)#152389ClinicalTrials.gov
• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)#861366ClinicalTrials.gov
• Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)#827994ClinicalTrials.gov
• Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer#4521Europe PMC
• Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer#346911ClinicalTrials.gov
• PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy#356479ClinicalTrials.gov
• NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell Lymphoma#432883ClinicalTrials.gov
• Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer#683078ClinicalTrials.gov
• CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer#832956ClinicalTrials.gov
• SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project#838374ClinicalTrials.gov
• GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma#838837ClinicalTrials.gov
• Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer#840432ClinicalTrials.gov
• Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC#842304ClinicalTrials.gov
• TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma#860953ClinicalTrials.gov
• Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer#864796ClinicalTrials.gov